MANKIND stock news on Anadi Algo News

Friday, March 27, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Stock Landing|1 matching stories

MANKIND Stock News, Sentiment & Trading Insights

Latest AI-analyzed news for MANKIND, including sentiment, related articles, and market-moving coverage.

Top Story|et_marketsabout 6 hours ago

Mankind Pharma shares in focus as Morgan Stanley initiates coverage with Overweight call. Check target, upside

Analyst coverage initiation with a positive rating often acts as a catalyst for stock price movement, especially for a prominent pharma company like Mankind Pharma. The sector is generally defensive.

buy
Bullish+61.390%
pharma
+61.3

Impact Score

Affected Stocks

MANKINDMankind Pharma Ltd
Positive
Long position in Mankind Pharma, targeting the ₹2,500 level, with a stop-loss below recent support levels.|Quick check: MANKIND neutral (+2.0% 1d), SUNPHARMA bullish bias (+2.7% 1d).